A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder

Journal of Autism and Developmental Disorders

Volumn 29, Issue 3, 1999, Pages 191-194

  Bolman, William M ^a   Richmond, John A ^b  

^a Tripler US Army Medical Center ^*  (United States)

^b TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

Autism; Dimethylglycine

Indexed keywords

AMINO ACID; DIMETHYLGLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; HUMAN; LEARNING; MALE; NEUROTRANSMISSION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MALE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SARCOSINE; VIDEO RECORDING;

EID: 0032807060     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023023820671     Document Type: Article

References (31)

1. The Advocate, Newsletter of the Autism Society of America. (1992). Vol. 2, p. 27. Balliet, M. (1992). Letters to the Editor: B6, magnesium and DMG. Autism Research Review International, 6(2), 6.
2. The Advocate, Newsletter of the Autism Society of America. (1992). Vol. 2, p. 27. Balliet, M. (1992). Letters to the Editor: B6, magnesium and DMG. Autism Research Review International, 6(2), 6.
3. Campbell M., & Palij, M. (1985). Behavioral and cognitive mesures used in psychopharmacological studies of infantile autism. The Children's Psychiatric Rating Scale (CPRS). Psychopharmacology Bulletin, 21, 1047-1050.
4. Cohen, D. J., & Volkmar, F. R. (Eds.). (1997). Handbook of autism and pervasive developmental disorders (2nd ed.). New York: Wiley.
5. Dawson G., & Osterling J. (1997). Early intervention in autism In M. J. Guralnick (Ed.), The effectiveness of early intervention (pp. 307-326). Baltimore, Paul H Brookes.
6. Doerfel, K. S. (1995). Letters to the Editor: Vitamin B6/DMG. Autism Research Review International, 9(2), 7.
7. Dunn, K. L. (1990). Letters to the Editor: DMG and vitamin B6. Autism Research Review International, 4(4), 7.
8. Gascon, G., Patterson, B., Yearwood K., & Slotnick, H. (1989). N,N-dimethylglycine and epilepsy. Epilepsia, 30(1), 90-93.
9. Gibbs, L. (1996). Letters to the Editor: B6 safety fear; DMG. Autism Research Review International, 10(3), 7.
10. Gillberg, C. (1991). Outcome in autism and autistic-like conditions. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 375-382.
11. Grandin, T., & Scariano, M. M. (1986). Emergence: Labeled autistic (p. 141). Novato, CA: Arena.
12. Hart, D. (1992). Letters to the Editor: B6, magnesium and DMG. Autism Research Review International, 6(2), 6.
13. Jelen, N. (1991). Letters to the Editor: More on B6 and DMG. Autism Research Review International, 5(2), 7.
14. Joss, L. (1991). Letters to the Editor: More on B6 and DMG. Autism Research Review International, 5(2), 7.
15. Kutzin A. (1992). Letters to the Editor: DMG, B6 successes Autism Research Review International, 6(1), 6-7
16. Los Angeles attorney. (1993). Letters to the Editor: DMG. Autism Research Review International, 7(1), 7.
17. McBain, C. J., & Mayer, M. L. (1994). N-methyl-D-aspartic acid receptor structure and function. Physiological Reviews, 74, 723-760.
18. McDougle, C. J. (1997). Psychopharmacology. In D. J. Cohen & F. R. Volkmar (Eds.), Handbook of autism and pervasive developmental disorders (pp. 707-729). New York, Wiley.
19. Monihan, M. (1990). Letters to the Editor: DMG. Autism Research Review International, 6(3), 6.
20. New York mother. (1992). Letters to the Editor: More success with DMG, B6. Autism Research Review International, 6(4),6.
21. O'Reilly, B. (1991) Letters to the Editor: DMG. Autism Research Review International, 5(3), 7.
22. Paul, I. A., Nowak, G., Layer, R. T., Popik, P., & Skolnick, P. (1994). Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. Journal of Pharmacology and Experimental Therapeutics, 269, 95-102.
23. Price, M. L. (1996). Letters to the Editor: Megavitamin/DMG therapy. Autism Research Review International, 10(4), 7.
24. Reznek, K. (1993). Letters to the Editor: DMG. Autism Research Review International, 7(2), 6.
25. Rimland, B. (1990). Dimethylglycine (DMG), a nontoxic metabolite, and autism. Autism Research Review International, 4(2), 3.
26. Schultz, N. (1992). Letters to the Editor: DMG, B6 successes. Autism Research Review International, 6(1), 6-7
27. Stittgen, S. (1990). Letters to the Editor: DMG and vitamin B6. Autism Research Review International, 4(4), 7.
28. Turuba, R. (1994). Letters to the Editor: B6/DMG. Autism Research Review International, 8(4), 7.
29. Valentine, S. (1993). Letters to the Editor: DMG. Autism Research Review International, 7(3), 6.
30. Venables, D., & Venables, P. (1994). Letters to the Editor: B6/DMG. Autism Research Review International, 8(4), 7.
31. Zhivago, K. (1993). Letters to the Editor: DMG. Autism Research Review International, 7(1). 7.